FSCN1 and breast cancer: Taken together our previous study's finding that fascin confers chemoresistance through FAK activation (5) and the present findings that fascin-mediated β-catenin signaling enhances CSC function in FAK-dependent manner, one could envisage the crucial role of this axis in breast cancer prognosis and the therapeutic potential of its targeting.